Catheter Precision, Inc. (VTAK)
NYSE American
Price as at 1 Oct 2026, 03:45 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Catheter Precision, Inc. trades at $0.15. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Catheter Precision, Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its VTAK data?
Fundamentals for VTAK come from company filings and exchange data, as listed on NYSE American; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 03:45 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for VTAK, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.